Cargando…
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854096/ https://www.ncbi.nlm.nih.gov/pubmed/36670412 http://dx.doi.org/10.1186/s12943-022-01699-2 |
_version_ | 1784873043061899264 |
---|---|
author | Okuno, Keisuke Kandimalla, Raju Mendiola, Marta Balaguer, Francesc Bujanda, Luis Fernandez-Martos, Carlos Aparicio, Jorge Feliu, Jaime Tokunaga, Masanori Kinugasa, Yusuke Maurel, Joan Goel, Ajay |
author_facet | Okuno, Keisuke Kandimalla, Raju Mendiola, Marta Balaguer, Francesc Bujanda, Luis Fernandez-Martos, Carlos Aparicio, Jorge Feliu, Jaime Tokunaga, Masanori Kinugasa, Yusuke Maurel, Joan Goel, Ajay |
author_sort | Okuno, Keisuke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9854096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98540962023-01-21 A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer Okuno, Keisuke Kandimalla, Raju Mendiola, Marta Balaguer, Francesc Bujanda, Luis Fernandez-Martos, Carlos Aparicio, Jorge Feliu, Jaime Tokunaga, Masanori Kinugasa, Yusuke Maurel, Joan Goel, Ajay Mol Cancer Correspondence BioMed Central 2023-01-20 /pmc/articles/PMC9854096/ /pubmed/36670412 http://dx.doi.org/10.1186/s12943-022-01699-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Okuno, Keisuke Kandimalla, Raju Mendiola, Marta Balaguer, Francesc Bujanda, Luis Fernandez-Martos, Carlos Aparicio, Jorge Feliu, Jaime Tokunaga, Masanori Kinugasa, Yusuke Maurel, Joan Goel, Ajay A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title_full | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title_fullStr | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title_full_unstemmed | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title_short | A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer |
title_sort | microrna signature for risk-stratification and response prediction to folfox-based adjuvant therapy in stage ii and iii colorectal cancer |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854096/ https://www.ncbi.nlm.nih.gov/pubmed/36670412 http://dx.doi.org/10.1186/s12943-022-01699-2 |
work_keys_str_mv | AT okunokeisuke amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT kandimallaraju amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT mendiolamarta amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT balaguerfrancesc amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT bujandaluis amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT fernandezmartoscarlos amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT apariciojorge amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT feliujaime amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT tokunagamasanori amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT kinugasayusuke amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT maureljoan amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT goelajay amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT okunokeisuke micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT kandimallaraju micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT mendiolamarta micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT balaguerfrancesc micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT bujandaluis micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT fernandezmartoscarlos micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT apariciojorge micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT feliujaime micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT tokunagamasanori micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT kinugasayusuke micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT maureljoan micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer AT goelajay micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer |